A New Era: FDA Approves Wegovy for Noncirrhotic MASH
- Metabolic dysfunction – Problems with how the body uses and processes energy (such as glucose and fats). Often associated with conditions like obesity, diabetes, and high cholesterol.
- Steatohepatitis (“Steato” = fat, “hepatitis” = liver inflammation): A condition where fat gradually collects in the liver, leading to inflammation and potential damage to liver cells.
- Fibrosis – The development of scar tissue or fibres in the organs caused by continued injury or inflammation.
- Inflammation – The body’s immune response to injury or damage. Inflammation can cause pain, swelling or loss of body function.
- Cirrhosis – Severe liver damage where healthy liver tissue is replaced by scar tissue. This causes the liver to become hard, less functional, and may lead to serious complications.
- Fatigue – Feeling extremely tired and low on energy can make daily tasks harder and less enjoyable.
- Phase 3 trial – A large clinical study testing how effective and safe a new drug or treatment is, usually involving thousands of patients before approval.
- Placebo – An inactive substance or dummy treatment (like a sugar pill) that looks the same as, and is given in the same way as, an active drug or treatment being tested. It is used in clinical trials to compare the effectiveness of the real drug.
⚠️ Disclaimer: This blog post is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new treatment, supplement, or health routine. The author and this blog are not responsible for any outcomes based on the information provided here.
